Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Icecure Medical Q2 2024 GAAP EPS $(0.06) Beats $(0.07) Estimate, Sales $1.01M Beat $925.50K Estimate

Author: Benzinga Newsdesk | August 20, 2024 08:39am
Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. The company reported quarterly sales of $1.01 million which beat the analyst consensus estimate of $925.50 thousand by 9.24 percent. This is a 7.90 percent increase over sales of $937.00 thousand the same period last year.

Posted In: ICCM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist